All news
Neutral impactOrders & Deals

Aarti Drugs Limited — Disclosure under SEBI Takeover Regulations

NSE 1 Jul·1 Jul 2026, 7:20 am

Harshit M. Savla has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Stocks in this story

Aarti Drugs377.90 0.00%

Key takeaways

  • Concerns Aarti Drugs (AARTIDRUGS).
  • Category: Orders & Deals.

Why it matters

A routine update for Aarti Drugs. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at NSE.

More Company news

More news

Latest headlines

More news

Aggregated from third-party sources for research. Sentiment & impact are AI-generated, indicative, not advice.

Aarti Drugs Limited — Disclosure under SEBI Takeover Regulations | Aarti Drugs (AARTIDRUGS)